• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

α-突触核蛋白相关翻译后修饰在帕金森病中的作用。

Effects of α-Synuclein-Associated Post-Translational Modifications in Parkinson's Disease.

机构信息

Department of Neurology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China.

Guangdong-Hong Kong-Macao Greater Bay Area Center for Brain Science and Brain-Inspired Intelligence, Guangzhou, Guangdong 510515, China.

出版信息

ACS Chem Neurosci. 2021 Apr 7;12(7):1061-1071. doi: 10.1021/acschemneuro.1c00028. Epub 2021 Mar 26.

DOI:10.1021/acschemneuro.1c00028
PMID:33769791
Abstract

α-Synuclein (α-syn), a small highly conserved presynaptic protein containing 140 amino acids, is thought to be the main pathological hallmark in related neurodegenerative disorders. Although the normal function of α-syn is closely involved in the regulation of vesicular neurotransmission in these diseases, the underlying mechanisms of post-translational modifications (PTMs) of α-syn in the pathogenesis of Parkinson's disease (PD) have not been fully characterized. The pathological accumulation of misfolded α-syn has a critical role in PD pathogenesis. Recent studies of factors contributing to α-syn-associated aggregation and misfolding have expanded our understanding of the PD disease process. In this Review, we summarize the structure and physiological function of α-syn, and we further highlight the major PTMs (namely phosphorylation, ubiquitination, nitration, acetylation, truncation, SUMOylation, and O-GlcNAcylation) of α-syn and the effects of these modifications on α-syn aggregation, which may elucidate mechanisms for PD pathogenesis and lay a theoretical foundation for clinical treatment of PD.

摘要

α-突触核蛋白(α-syn)是一种小而高度保守的突触前蛋白,包含 140 个氨基酸,被认为是相关神经退行性疾病的主要病理标志。虽然 α-syn 的正常功能与这些疾病中囊泡神经递质传递的调节密切相关,但帕金森病(PD)发病机制中 α-syn 的翻译后修饰(PTMs)的潜在机制尚未完全阐明。错误折叠的 α-syn 的病理性积累在 PD 的发病机制中起着关键作用。最近对导致 α-syn 相关聚集和错误折叠的因素的研究扩展了我们对 PD 疾病过程的理解。在这篇综述中,我们总结了 α-syn 的结构和生理功能,并且进一步强调了 α-syn 的主要 PTMs(即磷酸化、泛素化、硝化、乙酰化、截断、SUMO 化和 O-GlcNAc 化)及其对 α-syn 聚集的影响,这可能阐明 PD 发病机制的机制,并为 PD 的临床治疗奠定理论基础。

相似文献

1
Effects of α-Synuclein-Associated Post-Translational Modifications in Parkinson's Disease.α-突触核蛋白相关翻译后修饰在帕金森病中的作用。
ACS Chem Neurosci. 2021 Apr 7;12(7):1061-1071. doi: 10.1021/acschemneuro.1c00028. Epub 2021 Mar 26.
2
Exploring the Roles of Post-Translational Modifications in the Pathogenesis of Parkinson's Disease Using Synthetic and Semisynthetic Modified α-Synuclein.利用合成和半合成修饰的 α-突触核蛋白探索帕金森病发病机制中的翻译后修饰作用。
ACS Chem Neurosci. 2019 Feb 20;10(2):910-921. doi: 10.1021/acschemneuro.8b00447. Epub 2019 Jan 18.
3
Posttranslational Modifications of -Synuclein, Their Therapeutic Potential, and Crosstalk in Health and Neurodegenerative Diseases.- 突触核蛋白的翻译后修饰、它们的治疗潜力,以及在健康和神经退行性疾病中的相互作用。
Pharmacol Rev. 2024 Oct 16;76(6):1254-1290. doi: 10.1124/pharmrev.123.001111.
4
Targeting α-synuclein post-translational modifications in Parkinson's disease.靶向帕金森病中α-突触核蛋白的翻译后修饰。
Behav Brain Res. 2023 Feb 15;439:114204. doi: 10.1016/j.bbr.2022.114204. Epub 2022 Nov 11.
5
Role of post-translational modifications on the alpha-synuclein aggregation-related pathogenesis of Parkinson's disease.翻译后修饰在帕金森病α-突触核蛋白聚集相关发病机制中的作用
BMB Rep. 2022 Jul;55(7):323-335. doi: 10.5483/BMBRep.2022.55.7.073.
6
Role of post-translational modifications in modulating the structure, function and toxicity of alpha-synuclein: implications for Parkinson's disease pathogenesis and therapies.翻译:翻译后修饰在调节α-突触核蛋白的结构、功能和毒性中的作用:对帕金森病发病机制和治疗的影响。
Prog Brain Res. 2010;183:115-45. doi: 10.1016/S0079-6123(10)83007-9.
7
The role of posttranslational modifications of α-synuclein and LRRK2 in Parkinson's disease: Potential contributions of environmental factors.α-突触核蛋白和 LRRK2 的翻译后修饰在帕金森病中的作用:环境因素的潜在贡献。
Biochim Biophys Acta Mol Basis Dis. 2019 Aug 1;1865(8):1992-2000. doi: 10.1016/j.bbadis.2018.11.017. Epub 2018 Nov 24.
8
Alpha synuclein post translational modifications: potential targets for Parkinson's disease therapy?α-突触核蛋白的翻译后修饰:帕金森病治疗的潜在靶点?
Front Mol Neurosci. 2023 May 25;16:1197853. doi: 10.3389/fnmol.2023.1197853. eCollection 2023.
9
The Bidirectional Interplay of α-Synuclein with Lipids in the Central Nervous System and Its Implications for the Pathogenesis of Parkinson's Disease.α-突触核蛋白在中枢神经系统中与脂质的双向相互作用及其对帕金森病发病机制的影响。
Int J Mol Sci. 2023 Aug 26;24(17):13270. doi: 10.3390/ijms241713270.
10
Phosphorylation of α-Synuclein at Y125 and S129 alters its metal binding properties: implications for understanding the role of α-Synuclein in the pathogenesis of Parkinson's Disease and related disorders.α-突触核蛋白在 Y125 和 S129 位点的磷酸化改变了其金属结合特性:对理解 α-突触核蛋白在帕金森病及相关疾病发病机制中的作用的启示。
ACS Chem Neurosci. 2011 Nov 16;2(11):667-75. doi: 10.1021/cn200074d. Epub 2011 Sep 14.

引用本文的文献

1
Exploring the role of HIF-1α in pathogenesis of parkinson's disease and its potential as a therapeutic target.探索缺氧诱导因子-1α(HIF-1α)在帕金森病发病机制中的作用及其作为治疗靶点的潜力。
Mol Biol Rep. 2025 Sep 2;52(1):858. doi: 10.1007/s11033-025-10944-y.
2
Protective effects of paederoside in rotenone-induced cellular models of Parkinson's disease.车叶草苷在鱼藤酮诱导的帕金森病细胞模型中的保护作用。
Front Cell Dev Biol. 2025 Aug 7;13:1631652. doi: 10.3389/fcell.2025.1631652. eCollection 2025.
3
Protein kinases in neurodegenerative diseases: current understandings and implications for drug discovery.
神经退行性疾病中的蛋白激酶:当前认识及对药物研发的意义
Signal Transduct Target Ther. 2025 May 7;10(1):146. doi: 10.1038/s41392-025-02179-x.
4
Hypothermia Shifts Neurodegeneration Phenotype in Neonatal Human Hypoxic-Ischemic Encephalopathy but Not in Related Piglet Models: Possible Relationship to Toxic Conformer and Intrinsically Disordered Prion-like Protein Accumulation.体温过低改变新生儿缺氧缺血性脑病的神经退行性变表型,但在相关仔猪模型中未出现:与毒性构象和内在无序的朊病毒样蛋白积累的可能关系。
Cells. 2025 Apr 12;14(8):586. doi: 10.3390/cells14080586.
5
Fasudil inhibits α-synuclein aggregation through ROCK-inhibition-mediated mechanisms.法舒地尔通过ROCK抑制介导的机制抑制α-突触核蛋白聚集。
Neurotherapeutics. 2025 Mar;22(2):e00544. doi: 10.1016/j.neurot.2025.e00544. Epub 2025 Feb 5.
6
Dementia with lewy bodies patients with high tau levels display unique proteome profiles.tau蛋白水平高的路易体痴呆患者表现出独特的蛋白质组图谱。
Mol Neurodegener. 2024 Dec 19;19(1):98. doi: 10.1186/s13024-024-00782-0.
7
A Comprehensive Approach to Parkinson's Disease: Addressing Its Molecular, Clinical, and Therapeutic Aspects.帕金森病的综合治疗方法:探讨其分子、临床和治疗方面。
Int J Mol Sci. 2024 Jun 29;25(13):7183. doi: 10.3390/ijms25137183.
8
A Decade of Dedication: Pioneering Perspectives on Neurological Diseases and Mental Illnesses.十年奉献:关于神经疾病和精神疾病的开拓性观点
Biomedicines. 2024 May 13;12(5):1083. doi: 10.3390/biomedicines12051083.
9
Structural Investigations on 2-Amidobenzimidazole Derivatives as New Inhibitors of Protein Kinase CK1 Delta.2-氨基苯并咪唑衍生物作为蛋白激酶CK1δ新抑制剂的结构研究
Pharmaceuticals (Basel). 2024 Apr 7;17(4):468. doi: 10.3390/ph17040468.
10
Role of protein Post-translational modifications in enterovirus infection.蛋白质翻译后修饰在肠道病毒感染中的作用。
Front Microbiol. 2024 Feb 26;15:1341599. doi: 10.3389/fmicb.2024.1341599. eCollection 2024.